Foreign medical giants accelerate in China

A few days ago, Philips announced that the first batch of basic medical equipment developed and produced at the Suzhou plant was off the assembly line. Mr. Zhang Wenming, president of Philips Healthcare Greater China, said in an interview, Philips round strengthening R & D and production efforts in China, the Chinese domestic market are in-depth implementation of the strategy.

In fact, it is not the Philips family that foreign medical device companies are “deeply farming” in China. According to the news from the 2012 China International Medical Equipment Fair, foreign medical device companies such as Siemens and GE have launched innovative medical device products for basic medical care. Recently, GE Healthcare’s Greater China President and CEO Duan Xiaoyu said in an interview with the media that by the three years before 2015, we will double the capacity of China’s domestic market and fully realize the domestic industrial chain. Turn.

The continuous expansion of China's medical market has brought many opportunities to the medical device industry . In the eyes of many multinational giants, the Chinese market is unique. From the perspective of growth rate, China is an emerging market; from the perspective of medical device demand, the Chinese market is already a very mature market, that is to say, the rapid expansion of multinational companies in the Chinese market is the high quality of medical devices by Chinese users. High reliability and high service level are determined by comprehensive requirements.

In Li Jinying's view, the rural market has also become a potential market for multinational companies to compete for. In order to consolidate and expand its market share in China's medical device market, multinational companies are moving to medium and low through cooperation with Chinese companies and localized research and development. The end market penetrated deeply.

In recent years, with the continuous improvement of public medical conditions in China and the continuous advancement of medical system reform, China has become the fastest growing market in the medical device market.

According to statistics, in 2010, China's medical device industry was 7.446 billion US dollars, with a growth rate of 13.6%. The estimated price will reach 10.113 billion US dollars in 2013, and its annual compound growth rate is 13.94%, which is higher than global medical devices. The average growth rate of the market.

The above data shows that China's medical device market continues to grow, so it has always been the target of foreign giants. But the fact that is in front of us is that although China is a fast-growing market, almost all high-end medical devices are currently monopolized by foreign medical device companies.

In China's healthcare technology market, GE, Philips and Siemens account for most of the high-end market, with a conservative estimate of more than 70%.

According to the "2012 Medical Device Industry Analysis Report", although the data of medical device enterprises nationwide has reached more than 14,000, the competition pattern of the medical device industry is scattered, and the industry concentration is low. Most of them are small and medium-sized enterprises, although enterprises The number is large, but such companies are highly competitive and have low profitability, so they can only produce low-end products or provide spare parts for foreign companies.

At the 25th International Medical Instruments and Equipment Exhibition held recently, world-renowned medical device companies from Philips, GE, Siemens, Samsung and other world-famous medical device companies appeared at the show, which may indicate that China's medical device market is "promising."

From the perspective of market prospects, the acceleration of China's aging process, the continued advancement of urbanization and the upgrading of consumption structure have brought huge market space.

According to a forecast report from Zhongchuang Guofa, by 2016, the market size of China's medical device industry will reach 409.5 billion yuan. Compared with the market capacity of 434.54 billion yuan, there is still huge room for growth. The huge cake is enough to attract Foreign medical giants enter the Chinese market.

Sildenafil

Fla

Fladrafinil CRL-40 941 Bisfluroadrafinil

Describe :

99% CAS 90212-80-9 Norootropic Fladrafinil CRL 40 941 CRL-40,941

Good Sildenafil,Cosmetic Grade Cabomer 940,Creatine Monohydrate 99%,Gel Polymer Powder

Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptide-nootropics.com